Itoh Kunihiko, Kubo Wataru, Fujiwara Mariko, Watanabe Hideki, Miyazaki Shozo, Attwood David
Faculty of Pharmaceutical Sciences, Health Science University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, Japan.
Biol Pharm Bull. 2006 Feb;29(2):343-7. doi: 10.1248/bpb.29.343.
Dilute solutions of pectin containing complexed calcium ions form gels when these ions are released in the acidic environment of the stomach. The aim of this study was to examine the influence of a variation of gastric pH and the addition of a taste masking agent on the gelation of the pectin solutions and on the in vitro and in vivo release of acetaminophen from the gels. Increase of pH above 2.5 and addition of 10% (w/v) D-sorbitol significantly affected the ability of 1.5% (w/v) pectin solutions to form coherent gels in vitro. Gelation of sorbitol-free formulations was observed at pH 1.2 and in vitro release of acetaminophen from the gels followed diffusion-controlled kinetics; in vitro gelation of these formulations, however, was incomplete at pH 3.0 resulting in poor sustained release characteristics. Inclusion of 10% (w/v) D-sorbitol in the formulations inhibited the in vitro gelation of the 1.5% (w/v) pectin sols and poor sustained release properties were noted from these formulations even at pH 1.2. The bioavailability of acetaminophen from gels formed in the stomach of gastric-acidity controlled rabbits following oral administration of the liquid formulations was not, however, significantly affected either by the inclusion of 10% (w/v) D-sorbitol or increase of pH to 3.6. Visual observation showed in situ gelation of 1.5% (w/v) pectin formulations containing D-sorbitol at pH 4.3 suggesting that normal variations of gastric acidity in the fasting state will have no effect on the bioavailability of acetaminophen when delivered using these formulations.
含有络合钙离子的果胶稀溶液在胃的酸性环境中释放出这些离子时会形成凝胶。本研究的目的是考察胃内pH值变化和添加掩味剂对果胶溶液凝胶化以及对凝胶中对乙酰氨基酚体外和体内释放的影响。pH值升至2.5以上以及添加10%(w/v)D -山梨醇会显著影响1.5%(w/v)果胶溶液在体外形成连贯凝胶的能力。在pH 1.2时观察到无山梨醇制剂的凝胶化,且对乙酰氨基酚从凝胶中的体外释放遵循扩散控制动力学;然而,这些制剂在pH 3.0时体外凝胶化不完全,导致缓释特性不佳。制剂中加入10%(w/v)D -山梨醇会抑制1.5%(w/v)果胶溶胶的体外凝胶化,即使在pH 1.2时,这些制剂也表现出较差的缓释性能。然而,口服液体制剂后,在胃酸受控的兔胃中形成的凝胶中对乙酰氨基酚的生物利用度,并未因加入10%(w/v)D -山梨醇或pH值升至3.6而受到显著影响。视觉观察显示,含D -山梨醇的1.5%(w/v)果胶制剂在pH 4.3时会原位凝胶化,这表明在空腹状态下胃酸的正常变化对使用这些制剂给药时对乙酰氨基酚的生物利用度没有影响。